Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors
Regen BioPharma, Inc. has filed with the United States Patent and Trademark Office a provisional…
August 11, 2022 - 2 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
First patient enrolled on Panbela’s trial for treatment of pancreatic cancer
Panbela Therapeutics, a U.S.-based clinical stage company, announced today (August 11) that it has enrolled…
August 11, 2022 - 3 minutes
Research discovery may help diagnose and treat cancer and brain disorders
Researchers at Queen’s University Belfast in Northern Ireland have revealed how the pathway of an…
August 10, 2022 - 4 minutes
Captor Therapeutics names lead candidate in fight against hepatocellular carcinoma
A Polish biopharma company focused on treating cancer and autoimmune diseases announced today (August 10)…
August 10, 2022 - 3 minutes
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc…
August 9, 2022 - 3 minutes
Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
August 8, 2022 - 3 minutes
HUTCHMED drug in colorectal cancer trial meets primary endpoint
A trial to look at the use of a drug targeting refractory metastatic colorectal cancer…
August 8, 2022 - 3 minutes
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
August 8, 2022 - 2 minutes
Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE
This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at…
August 5, 2022 - 3 minutes
Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence
Sanofi and Innovent Biologics are to collaborate on providing medicines to patients in China with…
August 4, 2022 - 3 minutes
Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
August 4, 2022 - 3 minutes
New breast cancer treatment receives funding
Researchers at Queen’s University Belfast in Northern Ireland have received funding from Breast Cancer Now…
August 4, 2022 - 3 minutes
